Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Hospital Colônia Itapuã entre a saúde e o patrimônio

Quevedo ÉR, Primom JC. Editora Fi. 2024;
Download PDF
Publication

Hanseníase: tratamento e prevenção

Maganhin Luquetti C, Maria Eugênia Costa Casagrande , Victória Campos Giongo , et al. Nilton Lins University. Journal of Medical and Biosciences Research. 2024; 1 (4) : 131-141.
Download PDF
Publication

53590 Nasal Symptoms in Leprosy

Samra T, Herbert S, Maderal A. Journal of the American Academy of Dermatology. 2024;
Publication

54750 A Cross-Sectional Study to Evaluate the Role of the Nuclear Factor Kappa Beta (NF-κB) Pathway in Regulating the Cytokine Cascade and as a Potential Therapeutic Target in Leprosy

Chakraborty D, De A, Hena A. Elsevier BV. Journal of the American Academy of Dermatology. 2024;
Publication

Comorbidité lèpre et tuberculose: à propos de six cas

Dioussé P, Fall L, Lawson A, et al. Rev Mali Infectional Microbiological . 2018;
Download PDF
Publication

Socio-anthropologie d’une Maladie Tropicale Négligée dans une zone rurale du Niger : l’exemple de la lèpre à Danja et bourgades environnantes de Maradi

Ibrahim MMS, Mamane Sani SI, Abdoua ED. Revue LES TISONS. 2024;
Download PDF
Publication

Investigation of treating Leprosy (Hansen's Disease) from the perspective of the Akhlati medicine system in the history of Iran

ali parghoo M, silab AA. Journal for the History of Science. 2024;
Publication

Transforming Lives: A Qualitative Study Seeking Insights Into Reconstructive Surgery for Leprosy Patients in Western Maharashtra

Shrivastava K, Ray S, Rathod H, et al. Springer Science and Business Media LLC. Cureus. 2024;
Download PDF
Publication

Oral and perioral manifestations of leprosy: Report of a case

F. W, N. Epker B. Oral Surgery, Oral Medicine, Oral Pathology. 1969;
Publication

Type 1 reactions in leprosy, neuritis and steroid therapy: the impact of the human immunodeficiency virus

Bwire R, Kawuma H. Oxford University Press (OUP). Transactions of the Royal Society of Tropical Medicine and Hygiene. 1994; 88 (3) : 315-316.

Pagination

  • Previous page ‹‹
  • Page 66
  • Next page ››
Subscribe to Leprosy (Hansen disease)

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD